The ICD10 code for Aarskog-Scott Syndrome is Q87.1, while the ICD9 code is 759.89. Aarskog-Scott Syndrome is a genetic disorder characterized by facial, skeletal, and genital abnormalities. It primarily affects males and can cause short stature, facial anomalies, and developmental delays. The ICD10 and ICD9 codes are used for medical classification and billing purposes to identify and categorize specific conditions.
Aarskog-Scott Syndrome, also known as Aarskog syndrome or faciogenital dysplasia, is a rare genetic disorder that affects various parts of the body. It is characterized by distinctive facial features, short stature, and abnormalities in the skeletal, genital, and digital regions. The ICD10 code for Aarskog-Scott Syndrome is Q87.1, which falls under the category of "Congenital malformation syndromes predominantly affecting facial appearance."
In contrast, the ICD9 code for Aarskog-Scott Syndrome is 759.89, which falls under the category of "Other specified congenital anomalies." It is important to note that the transition from ICD9 to ICD10 occurred in 2015, so the ICD10 code provides a more specific classification for this particular syndrome.
Aarskog-Scott Syndrome is a multisystem disorder, affecting not only physical characteristics but also potentially causing developmental delays and intellectual disabilities. While it primarily affects males, females can also exhibit milder symptoms. Diagnosis is typically made based on clinical examination, family history, and molecular genetic testing.
Management of Aarskog-Scott Syndrome involves a multidisciplinary approach, addressing the specific needs of each individual. Treatment options may include corrective surgeries for skeletal abnormalities, hormone therapy for growth deficiencies, and early intervention programs to support developmental delays.
In conclusion, Aarskog-Scott Syndrome is a rare genetic disorder with distinctive physical features and various associated abnormalities. The ICD10 code for this syndrome is Q87.1, while the ICD9 code is 759.89. Proper diagnosis, early intervention, and comprehensive care are essential in managing the condition and improving the quality of life for individuals affected by this syndrome.